Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1960 2
1961 1
1962 4
1963 5
1964 8
1965 3
1966 8
1967 6
1968 7
1969 3
1970 3
1971 5
1972 2
1973 5
1974 14
1975 10
1976 13
1977 9
1978 10
1979 13
1980 10
1981 11
1982 12
1983 11
1984 12
1985 21
1986 24
1987 27
1988 34
1989 42
1990 32
1991 43
1992 34
1993 47
1994 45
1995 52
1996 42
1997 62
1998 65
1999 71
2000 82
2001 60
2002 70
2003 95
2004 79
2005 116
2006 99
2007 116
2008 105
2009 109
2010 86
2011 129
2012 128
2013 147
2014 143
2015 144
2016 139
2017 153
2018 185
2019 166
2020 215
2021 268
2022 225
2023 204
2024 201
2025 178

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,056 results

Results by year

Filters applied: . Clear all
Page 1
A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study).
Takahashi A, Nomoto H, Onishi K, Manda S, Miya A, Kameda H, Nakamura A, Atsumi T. Takahashi A, et al. Among authors: nakamura a. Diabetes Obes Metab. 2024 Aug;26(8):3471-3474. doi: 10.1111/dom.15639. Epub 2024 May 3. Diabetes Obes Metab. 2024. PMID: 38699794 Clinical Trial. No abstract available.
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC.
Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: nakamura a. J Thorac Oncol. 2021 Sep;16(9):1523-1532. doi: 10.1016/j.jtho.2021.03.027. Epub 2021 Apr 27. J Thorac Oncol. 2021. PMID: 33915251 Free article. Clinical Trial.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.
Miyauchi E, Morita S, Nakamura A, Hosomi Y, Watanabe K, Ikeda S, Seike M, Fujita Y, Minato K, Ko R, Harada T, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Miyauchi E, et al. Among authors: nakamura a. J Clin Oncol. 2022 Nov 1;40(31):3587-3592. doi: 10.1200/JCO.21.02911. Epub 2022 Aug 12. J Clin Oncol. 2022. PMID: 35960896 Free PMC article. Clinical Trial.
miR-29 is an important driver of aging-related phenotypes.
Swahari V, Nakamura A, Hollville E, Hung YH, Kanke M, Kurtz CL, Caravia XM, Roiz-Valle D, He S, Krishnamurthy J, Kapoor S, Prasad V, Flowers C, Beck M, Baran-Gale J, Sharpless N, López-Otín C, Sethupathy P, Deshmukh M. Swahari V, et al. Among authors: nakamura a. Commun Biol. 2024 Aug 27;7(1):1055. doi: 10.1038/s42003-024-06735-z. Commun Biol. 2024. PMID: 39191864 Free PMC article.
Prophylactic clip closure after endoscopic submucosal dissection of large flat and sessile colorectal polyps: a multicentre randomised controlled trial (EPOC trial).
Miyakawa A, Tamaru Y, Mizumoto T, Kanazawa N, Uchiyama S, Maehara K, Sumida Y, Nakamura A, Itobayashi E, Shimura H, Suzuki Y, Akita T, Shimura K, Kuwai T. Miyakawa A, et al. Among authors: nakamura a. Gut. 2025 Oct 8;74(11):1814-1820. doi: 10.1136/gutjnl-2024-334463. Gut. 2025. PMID: 40461060 Free article. Clinical Trial.
4,056 results